India, June 10 -- United Therapeutics Corp. (UTHR) shares fell 15.30 percent, or $50.26 on Tuesday, despite no new company-specific news driving the move. The sharp decline comes amid elevated trading volume and broader investor uncertainty. The stock is currently trading at $280.00, down from a previous close of $328.40 on the Nasdaq. It opened at $287.30 and has traded between $274.01 and $291.24 so far today, with volume spiking to 1.4 million shares, nearly triple the daily average. Over the past 52 weeks, shares have ranged from $266.98 to $417.82. The cause behind the sudden drop remains unclear, raising questions about potential market speculation or sector-related pressures.
For comments and feedback contact: editorial@rttnews.com...